Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00103298 | Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00006039 | Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 |
| clinicaltrials |
| NCT00043043 | Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00016250 | Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00020917 | Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00743678 | Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis | completed | Phase 2 | 73 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01281761 | Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC) | completed | Phase 2 | 52 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01322152 | Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer | completed | Phase 2 | 52 | Fudan UniversityOTHER | 1 | Jun 11, 2013 | clinicaltrials |
| NCT00027729 | Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00028626 | Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00220051 | A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer | completed | Phase 2 | 109 | Royal Marsden NHS Foundation TrustOTHER | 0 | May 31, 2013 | clinicaltrials |
| NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | completed | Phase 1 / Phase 2 | — | IntracelINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT01289288 | A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese(CRC) | completed | Phase 1 / Phase 2 | 480 | Georgetown UniversityOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00560560 | Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments | completed | Phase 2 | 168 | PfizerINDUSTRY | 3 | May 20, 2013 | clinicaltrials |
| NCT00785122 | IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101) | completed | Phase 1 / Phase 2 | 92 | Immatics Biotechnologies GmbHINDUSTRY | 9 | May 16, 2013 | clinicaltrials |
| NCT00808743 | Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis(PreDuoFAP) | completed | Phase 2 / Phase 3 | 37 | Radboud University Medical CenterOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00111774 | Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma | completed | Phase 2 | 150 | AmgenINDUSTRY | 0 | May 14, 2013 | clinicaltrials |
| NCT00290615 | Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 30 | Herbert HurwitzOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00005076 | Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | 110 | University of Alabama at BirminghamOTHER | 0 | Apr 12, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00258232 | Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00086931 | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 37 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00004066 | Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | completed | Phase 2 | 82 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | completed | Phase 2 | 24 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00004870 | Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 1 / Phase 2 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | completed | Phase 2 | 136 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00005085 | Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00052897 | SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003995 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00962494 | Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors | completed | Phase 2 | 585 | Stanford UniversityOTHER | 2 | Feb 7, 2013 | clinicaltrials |
| NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2013 | clinicaltrials |
| NCT00005864 | Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00444041 | Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer(ASSO-LM1) | completed | Phase 1 / Phase 2 | 43 | Austrian Society Of Surgical OncologyOTHER | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00005818 | SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00041340 | Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00378066 | Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer | completed | Phase 2 | 49 | Asan Medical CenterOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00005080 | 506U78 in Treating Patients With Lymphoma | completed | Phase 2 | 74 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00077259 | Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01116271 | Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec | completed | Phase 2 | 32 | AstraZenecaINDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00039273 | Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 44 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00784446 | First-line Therapy of Stage IV Colorectal Cancer | completed | Phase 1 / Phase 2 | 51 | University of CologneOTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT00049335 | S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed | completed | Phase 2 | 29 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00597506 | Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus(BEV/EV) | completed | Phase 2 | 50 | Herbert HurwitzOTHER | 1 | Dec 27, 2012 | clinicaltrials |
| NCT00466505 | Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 17 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Dec 19, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 20, 2013source: clinicaltrials